Quebec Woman Among First to Get New Alzheimer's Drug
A Longueil woman is among the first patients in Canada to receive a newly approved Alzheimer's drug designed to slow disease progression, marking a significant milestone in neurological treatment.
A Longueil woman is among the first patients in Canada to receive a newly approved Alzheimer's drug designed to slow disease progression, marking a significant milestone in neurological treatment.